Literature DB >> 2293437

Medical admissions to Kamuzu Central Hospital, Lilongwe, Malawi in 1986: comparison with admissions to Queen Elizabeth Central Hospital, Blantyre in 1973.

A D Harries1, R Speare, J J Wirima.   

Abstract

A retrospective survey was carried out on adult medical admissions to Kamuzu Central Hospital, Lilongwe, Malawi during the period January to December 1986, and results compared with those obtained in Queen Elizabeth Central Hospital, Blantyre in 1973. There were 4700 admissions which was more than twice the number seen in Blantyre. However, the age distribution, the pattern of disease and the overall hospital mortality were similar. Infections (malaria, pneumonia, tuberculosis, gastroenteritis/dysentery and meningitis) were the most common cause of admission, and the major causes of death were still tuberculosis, pneumonia and meningitis. Smoking related diseases were uncommon, and there was no documented case of ischaemic heart disease. The reasons for the importance of periodic surveys, such as the present study, are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2293437

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  3 in total

1.  Epidemiology of Respiratory Disease in Malawi.

Authors:  Stephen Gordon; Stephen Graham
Journal:  Malawi Med J       Date:  2006-09       Impact factor: 0.875

2.  Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosis.

Authors:  Nicholas A Feasey; Padmapriya P Banada; William Howson; Derek J Sloan; Aaron Mdolo; Catharina Boehme; Geoffrey A Chipungu; Theresa J Allain; Robert S Heyderman; Elizabeth L Corbett; David Alland
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

Review 3.  Medical causes of admissions to hospital among adults in Africa: a systematic review.

Authors:  Anthony O Etyang; John Anthony Gerard Scott
Journal:  Glob Health Action       Date:  2013-01-08       Impact factor: 2.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.